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Abstract
Background: Reference intervals for many laboratory 
parameters determined in 24-h urine collections are either 
not publicly available or based on small numbers, not sex 
specific or not from a representative sample.
Methods: Osmolality and concentrations or enzymatic 
activities of sodium, potassium, chloride, glucose, cre-
atinine, citrate, cortisol, pancreatic α-amylase, total 
protein, albumin, transferrin, immunoglobulin G, α1-
microglobulin, α2-macroglobulin, as well as porphyrins 
and their precursors (δ-aminolevulinic acid and porpho-
bilinogen) were determined in 241 24-h urine samples of a 
population-based cohort of asymptomatic adults (121 men 
and 120 women). For 16 of these 24 parameters creatinine-
normalized ratios were calculated based on 24-h urine 
creatinine. The reference intervals for these parameters 
were calculated according to the CLSI C28-A3 statistical 
guidelines.
Results: By contrast to most published reference inter-
vals, which do not stratify for sex, reference intervals of 12 
of 24 laboratory parameters in 24-h urine collections and 
of eight of 16 parameters as creatinine-normalized ratios 
differed significantly between men and women. For six 
parameters calculated as 24-h urine excretion and four 
parameters calculated as creatinine-normalized ratios no 
reference intervals had been published before. For some 
parameters we found significant and relevant deviations 
from previously reported reference intervals, most notably 
for 24-h urine cortisol in women. Ten 24-h urine param-
eters showed weak or moderate sex-specific correlations 
with age.
Conclusions: By applying up-to-date analytical methods 
and clinical chemistry analyzers to 24-h urine collections 
from a large population-based cohort we provide as yet the 
most comprehensive set of sex-specific reference intervals 
calculated according to CLSI guidelines for parameters 
determined in 24-h urine collections.
Keywords: 24-h urine collection; cortisol; electrolytes; 
porphyrins; proteinuria; reference interval.
Introduction
Aliquots of 24-h urine collections are classical specimens 
for the determination of renally excreted endogenous sub-
stances which have a strong intra-individual variation in 
response to daytime, dietary habits and prandial state, 
physical activity, fluid uptake or urine volume. One major 
drawback of this specimen is the inaccuracy in sampling. 
Normalization of analyte concentrations in spot urine 
for urinary creatinine helped to overcome this problem 
for some but not all urinary biomarkers. Another major 
limitation for the diagnostic use of laboratory parameters 
determined in 24-h urine samples is the uncertainty of 
reference intervals. The cumbersome 24-h collection of 
urines makes it difficult to obtain sufficient numbers of 
samples required for state-of-the-art derivation of refer-
ence intervals.
Here we present sex-specific reference intervals for 
frequently requested laboratory parameters as well as 
porphyrins calculated according to recent CLSI guidelines 
[1] in 24-h urine collections of a large population-based 
cohort of 241 asymptomatic adult European individu-
als. These urine parameters were measured by the use of 
modern clinical chemistry analyzers and present day ana-
lytical methods.
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Materials and methods
Participants
The participants to this reference interval study are living in the 
canton of Zurich, Switzerland (see Table 1 for more information 
about the study population) and they form a sub-cohort of the Swiss 
Study on Salt intake, a representative random population-based 
cross- sectional study about the salt intake in Switzerland, who con-
tributed 24-h urinary collections (for details see [2]). The study was 
approved by the Cantonal Ethics Committee Zurich, participation 
was voluntary and all participants gave written consent. Participants 
were instructed to collect urine in the container(s) without preserva-
tives for 24 h according to the standard procedure [3]. Briefly, they 
were told to empty their bladder upon awakening in the morning, 
discard that sample and collect thereafter all voided urine portions 
including next morning’s first urine in the container. The exact col-
lection time was recorded by each participant. A blood sample was 
also obtained from each participant to this reference interval study 
to determine serum creatinine for the estimation of the glomerular 
 filtration  rate  (GFR) [4]. Participants with an estimated GFR below 
60  mL/min/1.73  m2 or a 24-h urine collection of  < 600  mL were 
excluded from this study [5]. The final reference sample popula-
tion consisted of 120  women (mean age: 43 y, range 19–82 y) and 
121 men (mean age: 47 y, 20–89 y). Each 24-h urine collection was 
mixed and an aliquot of the mixed urine was centrifuged at 2000 g 
for 10 min. Measurements of electrolytes, osmolality, total protein, 
pancreatic α-amylase, glucose and creatinine were performed imme-
diately after centrifugation of the urine samples. Aliquots of the cen-
trifuged urine samples were stored at 2–8 °C before measurement of 
citrate,  albumin, α1-microglobulin, α2-macroglobulin, transferrin, 
and immuno globulin G (IgG) and at –20 °C before measurement of 
cortisol, porphyrins and their  precursors.
Laboratory tests
The concentrations or enzymatic activities of the following param-
eters were determined by the use of a cobas 8000 analyzer as 
well as reagents from Roche Diagnostics (Rotkreuz, Switzerland); 
the analytical method employed is given in parenthesis: sodium, 
potassium and chloride (all by ion selective electrodes), creati-
nine (rate-blanked Jaffé reaction [6], total protein (turbidimetry 
with benzethonium chloride), pancreas α-amylase (colorimetric 
test with antibody inhibition of human salivary α-amylase) and 
glucose (hexokinase method), The concentrations of albumin, 
α1-microglobulin, α2-macroglobulin, transferrin, and IgG were 
determined by immuno-nephelometry on a BN ProSpec (Siemens 
Healthcare Diagnostics, Marburg, Germany). The concentrations 
of the porphyrins (uroporphyrin, hepta-, hexa- and pentacar-
boxy porphyrins, coproporphyrin I and III) and their precursors 
(δ-aminolevulinic acid and porphobilinogen) were determined by 
HPLC with fluorescence detection [7] and by ion-exchange chro-
matography with spectrophotometric detection after reaction with 
modified Ehrlich’s reagent [8], respectively. Osmolality of the urine 
specimens was measured by freezing point depression (Advanced 
Instruments, Needham Heights, MA, USA). Citrate concentration 
was determined by an enzymatic UV-test (r-Biopharm, Darmstadt, 
Germany) on a Konelab 30i analyzer (Thermo Fisher Scientific, 
Vantaa, Finland). The cortisol concentration was determined by a 
chemiluminescent immunoassay without extraction of the analyte 
from the urine samples on an Access analyzer (Beckman Coulter, 
Nyon, Switzerland). For more details on the employed analytical 
methods see Table 2. Quality control material was analyzed in the 
same manner as the samples of the probands. The quality control 
was managed according to Swiss governmental regulations as 
defined by QUALAB (www.qualab.ch).
Data analysis
The reference intervals were determined for all participants as 
well as for women and men separately as the central 95% of the 
measurement results according to the CLSI C28-A3 statistical 
guidelines [1] using Reference Value Advisor [9], a set of macroin-
structions for Microsoft Excel (Microsoft, Redmond, WA, USA) 
developed for this purpose. The 2.5th and the 97.5th percentiles 
of the distribution of the test results represent the lower and the 
upper reference limit, respectively, and were annotated with 90% 
Table 1: Major characteristics of the study participants (percentage or mean±standard deviation). 
Parameter   Women (n = 120)  Men (n = 121)
Caucasian ethnicity, %   97  97
Age, years   43±18  47±18
Body height, cm   167±6  178±7
Body weight, kg   64.7±9.3  82.4±13.5
BMI, kg/m2   23.3±3.6  26.0±4.0
Diabetes mellitus, %   5  8
Hypertension, %   15  37
Oral anti-diabetic medication, %   0  3
Oral anti-hypertensive medication, %  7  18
Regular intake of medicaments, %   23  22
Current smoker, %   15  17
Urinary volume, mL/24 h   2205 (1600–2786)a  2040 (1440–2697)a
aFor urinary volume the median is given together with the 1st and 3rd quartiles in parenthesis.
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confidence intervals. Outliers within the data sets were identified 
and removed with the Tukey test [10] after Box-Cox transformation 
[11] of the data to approximate a normal distribution. However, 
the data of some parameters was not normally distributed even 
after Box-Cox  transformation (Andersen-Darling test). These data 
sets were  visually inspected (box-whisker plots) to identify and 
remove extreme values. Box-Cox transformation was then applied 
to the rest of the data and if the transformed data was normally 
 distributed the Tukey test was employed to identify and remove 
further outliers.
Quantities below the lower limit of quantitation (LLOQ) of the 
employed analytical method were assigned a value of LLOQ divided 
by the square root of two [12] for statistical data analysis. As recom-
mended by the CLSI C28-A3 statistical guidelines [1], the reference 
intervals and the 90% confidence intervals for the reference interval 
limits were calculated by the use of the non-parametric rank method 
and the robust method of Horn and Pesce [13] for partitions with at 
least 120 and with  < 120 reference values, respectively. Statistical 
analysis was performed with Microsoft Excel (Microsoft, Redmond) 
and IBM SPSS Statistics for Windows (Version 21.0, Armonk, NY, 
IBM Corp). Visual inspection of the data, Spearman’s, Pearson’s cor-
relation and least-square linear regression analysis were performed 
to infer age-dependency and the Mann-Whitney U-test to assess 
sex-dependency of the measured parameters. p-Values  < 0.05 were 
defined as statistically significant. Least-square regression analysis 
was performed only if all measurement results of a parameter were 
above the LLOQ of the employed analytical method and normally 
distributed.
Results
Table 3 shows the medians and reference intervals includ-
ing the 90% confidence intervals for the lower and the 
upper reference limits for 24 laboratory parameters quan-
tified in 24-h urine collections. Data are presented for the 
entire population as well as after stratification for men 
and women (see Table 3). Most of these data sets were 
not normally distributed. For half of the 24 parameters 
(creatinine, potassium, sodium, chloride, osmolality, 
cortisol, pancreatic α-amylase, δ-aminolevulinic acid, 
porphobilinogen, uroporphyrin, heptacarboxy porphy-
rin and coproporphyrin I) the upper and lower reference 
interval limits were higher in men than in women and the 
sex-dependency of the reference intervals was statistically 
significant.
Concentrations of cortisol, proteins, and porphy-
rins as well as their precursors in 24-h collections were 
also normalized for urinary creatinine concentrations 
(Table  4). In contrast to the higher absolute excreted 
amounts of the respective biomarkers in males, the cre-
atinine-normalized urinary concentrations of uroporphy-
rin, hepta-, hexa- and pentacarboxy porphyrins did not 
differ in a statistically significant manner between men 
Table 2: Characteristics of the employed analytical methods. 
Parameter   LLOQ  Linear 
range
  Between-run imprecision 
(coefficient of variation)
Creatinine, mmol/L   0.375  0.375–55    ≤  4.2%
Citrate, mmol/L   0.07  0.07–3.00    ≤  9%
Potassium, mmol/L/24 h   1  1–100    ≤  2.1%
Sodium, mmol/L   10  10–250    ≤  2.7%
Chloride, mmol/L   10  10–250    ≤  2.3%
Glucose, mmol/L    0.1  0.1–41.6    ≤  1.0%
Cortisol, μg/L   4  4–60    ≤  5.8%
Pancreatic-α-amylase, U/L   3  3–1500    ≤  2.2%
Total protein, g/L   0.04  0.04–2.00    ≤  1.4%
Albumin, mg/L   2.2  2.2–68    ≤  3.2%
Transferrin, mg/L   2.2  2.2–35    ≤  2.5%
Immunoglobulin G, mg/L   3.6  3.6–58    ≤  2.7%
α1-Microglobulin, mg/L   5.6  5.6–180    ≤  3.4%
α2-Macroglobulin, mg/L   2.7  2.7–85    ≤  3.8%
δ-Aminolevulinic acid, μmol/L   3.0  3.0–500    ≤  6.2%
Porphobilinogen, μmol/L   2.5  2.5–300    ≤  2.6%
Uroporphyrin, nmol/L   0.5  0.5–1600    ≤  10%
Heptacarboxyporphyrin, nmol/L   0.2  0.2–1500    ≤  12%
Hexacarboxyporphyrin, nmol/L   0.2  0.2–1600    ≤  25%
Pentacarboxy porphyrin, nmol/L   0.4  0.4–1600    ≤  7.5%
Coproporphyrin I, nmol/L   0.7  0.7–1500    ≤  7.5%
Coproporphyrin III, nmol/L   1.4  1.4–1500    ≤  5%
Total porphyrins, nmol/L   0.5  0.5–1600    ≤  11%
LLOQ, lower limit of quantification.
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and women. The upper reference interval limits of the cre-
atinine-normalized ratios of total protein, albumin, IgG, 
δ-aminolevulinic acid, coproporphyrin I and III and total 
porphyrins were even higher in women than in men.
Several parameters in 24-h urine samples showed 
statistically significant correlations with age (Table 5). 
However, only the inverse correlations of creatinine 
(Figure 1A and B) and total porphyrins with age were 
seen in either sex. Other correlations with age were seen 
in one sex only, e.g. in males the positive correlations of 
citrate (Figure 1), total protein and α1-microglobulin and 
the negative correlations of cortisol and coproporphyrin 
III. However, the negative correlations with age of sodium, 
chloride and coproporphyrin I were found for females 
only. To estimate the impact of age and hence the need 
of age-stratified reference intervals we calculated linear 
regression equations for normally distributed data sets. 
The absolute 24-h excretions showed mean changes per 
10  years aging (Table 5) in the range of 3%–13% with 
respect to the median of the measurement results of these 
parameters.
Discussion
We here report the reference intervals of 24 laboratory 
parameters determined in 24-h urine collections from a 
population-based sample of 241 asymptomatic adults. 
The parameters were chosen because they are regularly 
requested by clinicians of our hospital and determined 
by applying present day analytical methods to modern 
clinical chemistry analyzers. The reference intervals of 
these parameters were calculated according to recent 
CLSI-guidelines.
For 18 parameters we found reference intervals either 
published or provided by the test manufacturers and the 
majority of these reference intervals were very similar to 
those of our study. For creatinine, citrate (data of women) 
and potassium the published reference interval limits 
were within the 90% confidence interval of our reference 
interval limits. They were obtained by using the same 
analytical methods that were employed in our study. 
However, despite the use of the same analytical system 
and methods, reference intervals of several other 24-h 
urine parameters differed in a statistically significant and 
clinically meaningful manner between our and previous 
reports. These differences became even more prominent 
by the stratification of reference intervals for sex.
Except for creatinine, citrate, coproporphyrin I and 
III, none of the previously published reference intervals Pa
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was sex-specific. By contrast in our study, for most of the 
parameters a statistically significant sex-dependency of 
the reference intervals was found, the lower and the upper 
reference limits being higher for men than for women. 
Although statistically significant, the sex-specific differ-
ences of reference intervals found for some parameters 
are of minor clinical relevance depending on the clinical 
indication for determining this parameter.
On the contrary, cortisol is a prominent example for 
discrepant reference intervals with clinical relevance. 
The 24-h urinary excretion of cortisol is recommended by 
endocrinological societies as the screening test for ruling 
out Cushing’s syndrome [25] and should hence have a 
high diagnostic sensitivity. However, the test manufac-
turer provides a uniform reference interval with 14% and 
103% higher upper reference limits (403 μg/24 h) than 
those determined by us in men (351 μg/24 h) and women 
(199 μg/24 h), respectively. A similar considerable sex dif-
ference in the upper reference limit was previously found 
in a study of 83 men and 104 women which used LC-MS/MS 
for the determination of urinary cortisol [26]. Especially for 
women, this discrepancy has a major impact on diagnostic 
sensitivity in ruling out hypercortisolism. The discrepancy 
between our sex-specific cortisol reference intervals and 
the uniform one of the test manufacturer determined in 
140 apparently healthy adults is noteworthy, as the same 
analyzer and analytical method have been used.
Reference intervals of sodium concentrations were 
also concerned by important differences between the data 
provided either by our study or and the published uniform 
reference interval [16] cited by the test manufacturer 
(Table 3). The published upper reference limit of sodium 
excretion is 220 mmol/24 h [16] instead of 326 mmol/24 h 
for men in our study. Urinary electrolytes are known to 
show considerable intra- and inter-individual variations 
in response to changes in dietary intake. For sodium 
and potassium the intra-individual variation amounts to 
31% and 24%, respectively [27]. The sodium excretion in 
our sample was determined at steady state conditions to 
reduce this biological variation and to generate represent-
ative data. Therefore, the higher median (135 mmol/24 h) 
and upper reference level probably reflect the higher than 
recommended salt intake [28] in the Swiss population, 
which however is in agreement with many other studies 
[29, 30].
Previous urinary porphyrin measurements using frac-
tioned extractions [31] detected two fractions, the “uropor-
phyrin fraction” (uroporphyrin, heptacarboxy- and part of 
hexacarboxyporphyrins) and the “coproporphyrin frac-
tion” (rest of hexacarboxy-, pentacarboxy- and copropor-
phyrins). Reference values based on this technique are 
outdated, as in the 1980s, HPLC with fluorescence detec-
tion was introduced, first as normal then later as reverse 
phase chromatography. The latter is technical standard 
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Figure 1:  Scatter diagrams of 24-h urine creatinine for women (A), for men (B) and for 24-h urine citrate for women (C) and for men (D) 
versus age of the study participants.
The linear regression line, its slope, intercept and the statistical significance level are shown.
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today. Published reference intervals of urinary porphy-
rins based on this HPLC method are available for children 
[32, 33] and for adults [7, 20, 34]. Table 3 shows the refer-
ence intervals of 24-h urine porphyrins for adults from the 
study of Hindmarsh et al. [20] which was performed with 
the largest sample of the aforementioned reference inter-
val studies (96 adults). These reference intervals are in 
the same range as those of our study. However, it is worth 
mentioning that for porphyrin analysis a large inter-labo-
ratory variation has been reported recently [35].
For 16 of the 24 parameters we also calculated cre-
atinine-normalized excretions. Interestingly, this nor-
malization either eliminated statistically significant 
differences of reference intervals between men and 
women or led to the occurrence of higher reference limits 
in women than in men. These changes reflect the sig-
nificantly higher excretion of creatinine in men, which 
is the denominator of the ratios. Again we found some 
reference intervals being different from those published, 
e.g. for albumin, the porphyrins and their precursors. 
Some discrepant reference intervals may result from pre-
analytical differences in urine sampling. In clinical prac-
tice, specimens of second morning spot urines rather 
than 24-h urine collections are used for the determina-
tion of creatinine-normalized concentrations of urinary 
substances, e.g. for the differentiation and classification 
of proteinuria. In addition it is important to emphasize 
that clinical decision limits of some urinary parameters, 
e.g. albuminuria [19], have been defined by consensus 
of experts on the basis of clinical outcomes in epidemio-
logical or clinical intervention studies rather than on the 
frequency distribution in the population. Similarly to 
another reference interval study for proteinuria marker 
proteins [21] the concentrations of these proteins were 
below the LLOQ of the analytical methods for many of 
the urine samples of our study. These concentrations 
were replaced by LLOQ divided by the root square of two 
[12] for statistical analysis as well as the calculation of 
reference intervals. The reference interval obtained for 
IgG using this approach is very close to that of the afore-
mentioned study [21] with a similarly large 90% confi-
dence interval for the upper reference interval limit. The 
concentrations of transferrin and of α2-macroglobulin 
were above the corresponding LLOQ in only three and 
only in one out of 241 samples, respectively, i.e. in  < 2.5% 
of the samples. Thus the 97.5th percentile, i.e. the upper 
reference interval limit, is below the LLOQ for the con-
centrations of these two proteins, as reported by another 
study on urinary transferrin [22].
For many parameters including creatinine, cortisol 
or citrate we found statistically significant correlations 
between urinary excretion and age. Nevertheless we did 
not define any age-dependent reference intervals for the 
following reasons: Most importantly, further stratifica-
tion for age beyond sex would have yielded too small sub-
groups. Even a split by the median age of 36 and 47 years 
for women and men, respectively, would have generated 
groups of about 60 individuals and thereby large 90% 
confidence intervals for the reference interval limits. Fur-
thermore, our linear regression analysis revealed that 
the mean 24-h urinary excretion of the analyzed param-
eters changed only by 3%–13% within 10  years of aging 
with respect to the median of the measurement results. 
This change is within the inter-assay imprecision of the 
methods used (Table 2). However, we cannot exclude that 
for particular age groups, e.g. seniors  > 70 years for which, 
however, only few data points are available in our study 
cohort, the mean relative change of 24-h urinary excretion 
of particular parameters per unit year aging is larger than 
expected by extrapolation.
Our reference interval study has several strengths and 
limitations. The major progress is the sample size which 
is larger than in most previous studies and allowed the 
determination of reference intervals with the non-para-
metric rank method recommended by the CLSI C28-A3 
statistical guidelines [1]. As one limitation our population-
based cohort, includes individuals with diabetes mellitus, 
hypertension, or regular intake of medicines (Table 1). 
These conditions may affect the urinary excretion of some 
parameters (e.g. albumin, total protein, glucose). To com-
pensate for these uncertainties we used the Tukey test [10] 
and visual inspection of the data for the detection of outli-
ers which were removed from the data set before calcula-
tion of reference intervals. Furthermore individuals with 
an estimated GFR  < 60 mL/min/1.73  m2 were excluded 
from this study. Another weakness of this study is inher-
ent with the sampling of 24-h urines in the population. 
Although the volunteers participating in our study were 
carefully instructed on the procedure of 24-h urine collec-
tion and only 24-h urine collections of more than 600 mL 
were included in this study, we cannot exclude incomplete 
specimen collection by some participants. As discussed 
before, reference intervals of some of the 16 parameters 
relative to urinary creatinine may differ from previously 
reported ones because we analyzed them in 24-h urine 
collections rather than in the conventional morning spot 
urine.
In conclusion, we here provide a clinically helpful 
resource of sex-specific reference intervals for 24 clinically 
relevant laboratory parameters determined in 24-h urine 
collections and for 16 parameters calculated as creatinine-
normalized ratios.
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